These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29994804)
41. Comparison of multivessel percutaneous coronary intervention and coronary artery bypass grafting in patients with severe coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes. Desperak P; Hawranek M; Hrapkowicz T; Zembala MO; Gąsior M Kardiol Pol; 2018; 76(10):1474-1481. PubMed ID: 30251246 [TBL] [Abstract][Full Text] [Related]
42. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. Garcia S; Sandoval Y; Roukoz H; Adabag S; Canoniero M; Yannopoulos D; Brilakis ES J Am Coll Cardiol; 2013 Oct; 62(16):1421-31. PubMed ID: 23747787 [TBL] [Abstract][Full Text] [Related]
43. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease. De Luca G; Schaffer A; Verdoia M; Suryapranata H Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711 [TBL] [Abstract][Full Text] [Related]
44. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214 [TBL] [Abstract][Full Text] [Related]
45. Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis. Ariyaratne TV; Ademi Z; Yap CH; Billah B; Rosenfeldt F; Yan BP; Reid CM Int J Cardiol; 2014 Sep; 176(2):346-53. PubMed ID: 25127976 [TBL] [Abstract][Full Text] [Related]
46. Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus. Li Y; Dong R; Hua K; Liu TS; Zhou SY; Zhou N; Zhang HJ Chin Med J (Engl); 2017 Dec; 130(24):2906-2915. PubMed ID: 29237922 [TBL] [Abstract][Full Text] [Related]
47. Improved long-term survival for diabetic patients with surgical versus interventional revascularization. Kurlansky P; Herbert M; Prince S; Mack MJ Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668 [TBL] [Abstract][Full Text] [Related]
48. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304 [TBL] [Abstract][Full Text] [Related]
49. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials. Al Ali J; Franck C; Filion KB; Eisenberg MJ JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647 [TBL] [Abstract][Full Text] [Related]
50. An optimal strategy for coronary revascularization in patients with severe renal dysfunction. Komiya T; Ueno G; Kadota K; Mitsudo K; Okabayashi H; Nishiwaki N; Hanyu M; Kimura T; Tanaka S; Marui A; Sakata R; Eur J Cardiothorac Surg; 2015 Aug; 48(2):293-300. PubMed ID: 25416698 [TBL] [Abstract][Full Text] [Related]
51. Has the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regression. Herbison P; Wong CK BMJ Open; 2015 Dec; 5(12):e010055. PubMed ID: 26719324 [TBL] [Abstract][Full Text] [Related]
52. Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction. Nagendran J; Bozso SJ; Norris CM; McAlister FA; Appoo JJ; Moon MC; Freed DH; Nagendran J J Am Coll Cardiol; 2018 Feb; 71(8):819-827. PubMed ID: 29471931 [TBL] [Abstract][Full Text] [Related]
53. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis. Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139 [TBL] [Abstract][Full Text] [Related]
55. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†. Marui A; Kimura T; Nishiwaki N; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R; Eur J Cardiothorac Surg; 2015 Feb; 47(2):316-21; discussion 321. PubMed ID: 24662243 [TBL] [Abstract][Full Text] [Related]
56. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease. Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park SW; Serruys PW; Park SJ Catheter Cardiovasc Interv; 2017 Aug; 90(2):177-185. PubMed ID: 28112467 [TBL] [Abstract][Full Text] [Related]
57. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215 [TBL] [Abstract][Full Text] [Related]
58. Real-life characteristics and outcomes of patients who undergo percutaneous coronary intervention versus coronary artery bypass grafting for left main coronary artery disease: data from the prospective Multi-vessel Coronary Artery Disease (MULTICAD) Israeli Registry. Ram E; Goldenberg I; Kassif Y; Segev A; Lavee J; Einhorn-Cohen M; Raanani E Eur J Cardiothorac Surg; 2018 Oct; 54(4):717-723. PubMed ID: 29554237 [TBL] [Abstract][Full Text] [Related]
59. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490 [TBL] [Abstract][Full Text] [Related]
60. Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease. Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL Circ Cardiovasc Interv; 2015 Jul; 8(7):e002626. PubMed ID: 26156152 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]